Acta Pharmaceutica Sinica B

Aims & Scope

Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Preservation url
• Apc url
• License

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,600.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

  Citation: 1675

  Authors: Canrong, Yang, Yueying, Peng, Wu, Yali, Qiqi, Yang, Mingxue, Xingzhou, Mengzhu, Lixia, Hua

• HIF-1α pathway: role, regulation and intervention for cancer therapy

  Citation: 1533

  Authors: Georgina N., Wei

• Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges

  Citation: 1122

  Authors: Dinh, Ningning, Venkatareddy

• Insoluble drug delivery strategies: review of recent advances and business prospects

  Citation: 1118

  Authors: Sandeep, Vijaykumar

• Why 90% of clinical drug development fails and how to improve it?

  Citation: 1084

  Authors: Duxin, Wei, Hongxiang, Simon

• Cancer metastases: challenges and opportunities

  Citation: 758

  Authors: Xiangming

• Recent progress in drug delivery

  Citation: 684

  Authors: Chong, Jiancheng, Yiguang, Huile, Gang, Yongzhuo, Haijun, Yong, Yongjun, Lin, Huabing, Haiyan, Zhiping, Yiguang

• Mesoporous silica nanoparticles for drug and gene delivery

  Citation: 595

  Authors: Yixian, Guilan, Qiaoli, Xiaoxu, Boyi, Biyuan, Ying, Xin, Chuanbin

• Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application

  Citation: 546

  Authors: Qing, Yongtai, Zhe, Xuefeng, Nianping

• Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

  Citation: 546

  Authors: Sisi, Mei, Zhongsi, Liping, Zhaoxia, Xiaoxue, Suhua, Ziliang, Zhechong, Qiuyue, Yan, Changsheng, Hong, Shoudeng